Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Verrica Pharmaceuticals Inc. (VRCA) had Stock-Based Compensation of $1.91M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$12.70M |
|
$0.20M |
|
$0.49M |
|
$12.21M |
|
$11.19M |
|
$1.51M |
|
$-1.31M |
|
$0.20M |
|
$0.20M |
|
$0.20M |
|
$0.20M |
|
$0.20M |
|
$0.20M |
|
$1.51M |
|
$1.71M |
|
9.49M |
|
9.49M |
|
$0.02 |
|
$0.02 |
|
| Balance Sheet Financials | |
$36.78M |
|
$0.32M |
|
$2.33M |
|
$39.11M |
|
$29.22M |
|
$25.16M |
|
$27.37M |
|
$56.59M |
|
$-17.48M |
|
$-17.48M |
|
$-17.48M |
|
9.25M |
|
| Cash Flow Statement Financials | |
$-22.72M |
|
-- |
|
$-8.21M |
|
$46.33M |
|
$15.40M |
|
$-30.93M |
|
|
Stock-Based Compensation |
$1.91M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.26 |
|
-- |
|
-- |
|
3.28 |
|
-2.18 |
|
96.11% |
|
11.89% |
|
11.89% |
|
-- |
|
1.61% |
|
1.61% |
|
$-22.72M |
|
-- |
|
-- |
|
-- |
|
0.32 |
|
0.20 |
|
0.73 |
|
123.08 |
|
-1.17% |
|
-1.17% |
|
0.52% |
|
2.66% |
|
$-1.89 |
|
$-2.39 |
|
$-2.39 |
|